Characterisation of the Novel HLA ‐ DRB4 *01:193 Allele by Sequencing‐Based Typing
HLA · 2025
DOI: 10.1111/tan.70308 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Lucie Blandin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Alleles, Exons, HLA-DRB4 Chains, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
HLA‐DRB4*01:193 differs from HLA‐DRB4*01:03:01:01 by one nucleotide substitution in codon 166 in exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
- Clermont-Auvergne University, EA7453 CHELTER, Clermont-Ferrand, France.
- CHU de Bordeaux, Laboratoire D'immunologie et Immunogénétique, Bordeaux, France.
ORCID-Profile: Paul Rouzaire
Zitieren
APA
Blandin, L., Wojciechowski, E., Ralazamahaleo, M., Lemal, R., & Rouzaire, P. (2025). Characterisation of the Novel HLA ‐ DRB4 *01:193 Allele by Sequencing‐Based Typing. HLA. https://doi.org/10.1111/tan.70308
Vancouver
Blandin L, Wojciechowski E, Ralazamahaleo M, Lemal R, Rouzaire P. Characterisation of the Novel HLA ‐ DRB4 *01:193 Allele by Sequencing‐Based Typing. HLA. 2025. doi:10.1111/tan.70308
BibTeX
@article{Blandin2025,
author = {Blandin, Lucie and Wojciechowski, Elodie and Ralazamahaleo, Mamy and Lemal, Richard and Rouzaire, Paul},
title = {Characterisation of the Novel HLA ‐ DRB4 *01:193 Allele by Sequencing‐Based Typing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70308}
}
EUVIMED